The therapeutic components and propellants in the container of Spray Laríngeo Original, together with its nasopharyngeal cannula, originated this brand new therapeutic product that permits a direct application with exact dosage capabilities on target organs in upper respiratory diseases in sport equines.

Horses with upper airway inflammatory obstructions, infectious or not, can keep on training with the application of Spray Laríngeo Original by means of its nasopharyngeal cannula.

Spray Laríngeo Original, due to its propelling force with fine drops, is the only device that deposits the medication on the mucoses of the upper respiratory airways permitting the exact application and dosage on the area to be treated: ethmoid, larynx, pharynx, guttural pouches, and also reaches the guttural pouches through their openings under fibroscopic control.

A wide spectrum fungicide with an anti-inflammatory, carried by a solvent of extraordinary pharmacological features, makes it possible to be absorbed through the tissular membranes of the active substances dissolved in it.

Spray Laríngeo Original has an incredible anti-inflammatory, desensitizing, analgesic, antimicotic and bactericidal power.

The solution must be used only locally through the corresponding cannula.

Easy to
use.

COMPOSITION:

Dexamethasone: 0,05 g; Nitrofurazone: 2 g; Miconazole: 2g; Dimethyl Sulfoxide: 50 g;
Excipients and propellants c.s.p. 100 g.




THERAPEUTIC USE:

Only for local use in horses. The association of an antifungous wide spectrum agent such as Miconazole with Nitrofurazone a bactericidal of wide spectrum, and an anti-inflammatory such as Dexamethasone in a carrier such as Dimethyl Sulfoxide, a solvent with extraordinary pharmaceutical properties, that permits absorption of the active substances it contains through the mucous membrane. In addition to its powerful anti-inflammatory, decongestive, analgesic and bacteriostatic properties, this solution is extremely practical and should only be applied locally. The pressurized container with the solution is connected to the nasopharyngeal cannula and the product is expelled through the latter in the form of a spray into the nasal, ethmoidal, pharyngeal and laryngeal areas, with the appropriate dosage.

INSTRUCTIONS:

Only to be used locally in inflammatory lesions of the respiratory passage's mucosa whether infected or not (nasal, ethmoidal, pharyngeal and laryngeal). Bacterial, micotic and viral Infections of the mentioned areas. Coughing, laryngitis, pharyngitis, pharyngeal lymphoid hyperplasia. Nasal, ethmoidal, pharyngeal and laryngeal hemorrhages. Ethmoid Hematomas. Ulcers of the nasal, ethmoidal, pharyngeal, soft palate and laryngeal mucosa. Infections, suppuration and inflammatory obstructions of the guttural pouches and openings to the pharynx. Strangles (streptococcus equi), guttural pouch empyema. Allergy to hay mold and recovery from a viral infection. Epiglottal entrapment, vocal fold lesions, aryepiglottic entrapment and pharyngitis, epiglottitis. Post surgery treatment of pharyngeal, soft palate and laryngeal areas. Chondritis of the arytenoid cartilage. Progressive pharyngeal scarring.

DOSAGE
& ADMINISTRATION:

For local use only in the above mentioned affections using the cannula enclosed. Introduce the cannula through the ventral meatus until reaching the zone to be treated; attach the pressurized container. Press down for 1 puff and repeat the operation on the other side. The treatment should be applied twice daily in both nostrils during 3 days without interruption.

PRECAUTIONS:

Even though this solution should be used locally, it is advisable that administration be controlled by the acting Medical Veterinarian during the recommended period of time. Do not use the same cannula on two different animals and always disinfect after each application.

SECONDARY
& COLATERAL REACTIONS:

The treatment should not be extended beyond the limit of time advised nor should higher doses be applied than those indicated. Should the recommended medication be altered, reactions of skin and mucous hipersensibility may appear. Scaling of the mucous epithelium, as a consequence of a prolonged treatment (over 96 hours of medication), or by an increase in the recommended daily dose, can be detected by an endoscopy performed by the acting Veterinarian.

PRESENTATION:

Spray Laríngeo Original in 5 oz. pressurized container with 100 g. net content, with nasopharyngeal cannula and special adapter (sold separately) for needle.